3rd Quarter - Report

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$550,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to free trade agreements in European Union and Asia.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: State, Dept of (DOS); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE

Economics/Economic Development ECN

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: SENATE; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS)

Bills named: H.R. 2052 (113th), S. 1023 (113th)

Taxation/Internal Revenue Code TAX

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax); S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control);S. 2786 Corporate Inverters Earnings Stripping Reform Act;

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: SENATE; Natl Security Council (NSC); U.S. Trade Representative (USTR); State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: S. 232 (113th), S. 2786 (113th), H.R. 523 (113th), H.R. 4679 (113th), S. 95 (113th), S. 2360 (113th), H.R. 4985 (113th)

Health Issues HCR

Issues relating to implementation of provisions of the Food and Drugs Administration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures. Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring. Issue related to medicare coverage of early lung cancer screening. Issues related to the 21st Century Cures initiative, a priority of the House Energy and Commerce Committee.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Security Council (NSC); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.